B3GALT9
Beta-1,3-galactosyltransferase 9
Also known as: B3GNT10, B3GT9_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A8MXE2
- Gene
- B3GALT9
- Ensembl
- ENSG00000214654
- Chromosome
- 9
- Canonical length
- 369 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable glycosyltransferase activity. Predicted to be involved in protein O-linked glycosylation. Predicted to be located in Golgi apparatus and membrane. Predicted to be active in Golgi membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
369 residues, UniProt reviewed canonical sequence.
>A8MXE2|B3GALT9
1 MQVTFCRLRT HQWCFILFNV ILFHALLFGT DFVEEYFLHS LPYIDVKVLE IKNKARKLNI
61 EPLRSNLSKY YVLSQSEICK GKNIFLLSLI FSSPGNGTRR DLIRKTWGNV TSVQGHPILT
121 LFALGMPVSV TTQKEINKES CKNNDIIEGI FLDSSENQTL KIIAMIQWAV AFCPNALFIL
181 KVDEETFVNL PSLVDYLLNL KEHLEDIYVG RVLHQVTPNR DPQNRDFVPL SEYPEKYYPD
241 YCSGEAFIMS QDVARMMYVV FKEVPMMVPA DVFVGICAKF IGLIPIHSSR FSGKRHIRYN
301 RCCYKFIFTS SEIADPEMPL AWKEINDGKE CTLFETSYEL ISCKLLTYLD SFKRFHMGTI
361 KNNLMYFADLocalizationUniProt · AlphaFold · HPA
Whether an antibody against B3GALT9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 5.7 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 5.7 nTPM
- epididymis: 3.1 nTPM
- lymph node: 3 nTPM
- thyroid gland: 2.9 nTPM
- kidney: 2.6 nTPM
- stomach: 2.6 nTPM
Single-cell type
- cardiomyocytes: 61 nCPM
- late spermatids: 48 nCPM
- epicardial cells: 30 nCPM
- early spermatids: 18 nCPM
- adipocytes: 15 nCPM
- tuft cells: 12 nCPM
Immune cell
- NK-cell: 2.2 nTPM
- eosinophil: 1.8 nTPM
- gdT-cell: 1.8 nTPM
- naive CD4 T-cell: 1.8 nTPM
- memory CD8 T-cell: 1.7 nTPM
- T-reg: 1.7 nTPM
Brain region
- white matter: 13 nTPM
- cerebellum: 10 nTPM
- choroid plexus: 9.7 nTPM
- basal ganglia: 9 nTPM
- medulla oblongata: 8.9 nTPM
- pons: 8.7 nTPM
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads B3GALT9 as an antibody target. Whether an autoantibody or antibody against B3GALT9 could matter depends on whether native B3GALT9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
B3GALT9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label B3GALT9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...